Cargando…

Prognosis of Sentinel Node Staged Patients with Primary Cutaneous Melanoma

BACKGROUND: This study investigated survival probabilities and prognostic factors in sentinel lymph node biopsy (SLNB) staged patients with cutaneous melanoma (CM) with the aim of defining subgroups of patients who are at higher risk for recurrences and who should be considered for adjuvant clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elsaeßer, Otmar, Leiter, Ulrike, Buettner, Petra G., Eigentler, Thomas K., Meier, Friedegund, Weide, Benjamin, Metzler, Gisela, Breuninger, Helmut, Garbe, Claus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261856/ https://www.ncbi.nlm.nih.gov/pubmed/22276129 http://dx.doi.org/10.1371/journal.pone.0029791

Ejemplares similares

Melanoma Patients with Unknown Primary Site or Nodal Recurrence after Initial Diagnosis Have a Favourable Survival Compared to Those with Synchronous Lymph Node Metastasis and Primary Tumour
por: Weide, Benjamin, et al.
Publicado: (2013)

Prognostic Factors of Melanoma Patients with Satellite or In-Transit Metastasis at the Time of Stage III Diagnosis
por: Weide, Benjamin, et al.
Publicado: (2013)

Serum S100B, Lactate Dehydrogenase and Brain Metastasis Are Prognostic Factors in Patients with Distant Melanoma Metastasis and Systemic Therapy
por: Weide, Benjamin, et al.
Publicado: (2013)

Quantitative Measurement of Melanoma Spread in Sentinel Lymph Nodes and Survival
por: Ulmer, Anja, et al.
Publicado: (2014)

Effectiveness of Carboplatin and Paclitaxel as First- and Second-Line Treatment in 61 Patients with Metastatic Melanoma
por: Pflugfelder, Annette, et al.
Publicado: (2011)

Development of an Image Analysis-Based Prognosis Score Using Google’s Teachable Machine in Melanoma
por: Forchhammer, Stephan, et al.
Publicado: (2022)

BRAF-V600 Mutations Have No Prognostic Impact in Stage IV Melanoma Patients Treated with Monochemotherapy
por: Meckbach, Diana, et al.
Publicado: (2014)

Determinants of survival in patients with brain metastases from cutaneous melanoma
por: Staudt, M, et al.
Publicado: (2010)

Sentinel lymph node biopsy for high-thickness cutaneous squamous cell carcinoma
por: Kofler, Lukas, et al.
Publicado: (2020)

Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors
por: Gassenmaier, Maximilian, et al.
Publicado: (2021)

Hidden Sentinel Node in Cutaneous Melanoma
por: Segreto, Francesco, et al.
Publicado: (2013)

Cutaneous Melanoma and Sentinel Lymph Node Biopsy
por: van Akkooi, A. C. J., et al.
Publicado: (2008)

Missing sentinel lymph node in cutaneous melanoma
por: Dellavedova, Luca, et al.
Publicado: (2015)

S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies
por: Wagner, Nikolaus B, et al.
Publicado: (2018)

Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany
por: KRAMB, Felix, et al.
Publicado: (2022)

Survival According to BRAF-V600 Tumor Mutations – An Analysis of 437 Patients with Primary Melanoma
por: Meckbach, Diana, et al.
Publicado: (2014)

Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis
por: Weide, B, et al.
Publicado: (2012)

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade
por: Bochem, Jonas, et al.
Publicado: (2019)

An open-label, single-arm, phase II trial of buparlisib in patients with melanoma brain metastases not eligible for surgery or radiosurgery—the BUMPER study
por: Amaral, Teresa, et al.
Publicado: (2020)

Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma
por: El Sharouni, Mary-Ann, et al.
Publicado: (2019)

Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases
por: Niessner, Heike, et al.
Publicado: (2013)

Subcostal lymph nodes: An unusual sentinel lymph node basin in cutaneous melanoma
por: Marsh, Katherine M., et al.
Publicado: (2022)

Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma
por: Gaißler, Andrea, et al.
Publicado: (2023)

Interval Sentinel Lymph Nodes: An Unusual Localization in Patients with Cutaneous Melanoma
por: Manganoni, A. M., et al.
Publicado: (2011)

Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma
por: Schmalbach, Cecelia E., et al.
Publicado: (2018)

Sentinel Lymph Node Biopsy in Patients With Thick Primary Cutaneous Melanoma
por: Rodriguez Otero, Juan Carlos, et al.
Publicado: (2019)

Evaluation of tumor load in sentinel lymph node in patients with cutaneous melanoma
por: ALMEIDA, PEDRO DEAK DE, et al.
Publicado: (2023)

Primary Resistance to PD-1-Based Immunotherapy—A Study in 319 Patients with Stage IV Melanoma
por: Amaral, Teresa, et al.
Publicado: (2020)

Effective Combination of Photodynamic Therapy and Imiquimod 5% Cream in the Treatment of Actinic Keratoses: Three Cases
por: Held, Laura, et al.
Publicado: (2013)

Lymphangiogenesis and Its Correlation with the VEGF Expression and the Sentinel Lymph Node in Cutaneous Melanomas
por: Buzrla, Petr, et al.
Publicado: (2014)

Sentinel lymph node biopsy for cutaneous melanoma: A 6 years study
por: Sánchez, Jaime Lima, et al.
Publicado: (2013)

Population-based assessment of sentinel lymph node biopsy in the management of cutaneous melanoma
por: Ollek, Sita, et al.
Publicado: (2022)

Diagnostic biopsy of cutaneous melanoma, sentinel lymph node biopsy and indications for lymphadenectomy
por: Pavlidis, Efstathios T, et al.
Publicado: (2022)

Sentinel Lymph Node Biopsy in Cutaneous Melanoma, a Clinical Point of View
por: Brănişteanu, Daciana Elena, et al.
Publicado: (2022)

Melanocytic nevi in sentinel lymph nodes: association with cutaneous nevi and clinical relevance in patients with cutaneous melanomas
por: Kretschmer, Lutz, et al.
Publicado: (2022)

Clinicopathologic models predicting non‐sentinel lymph node metastasis in cutaneous melanoma patients: Are they useful for patients with a single positive sentinel node?
por: Rentroia‐Pacheco, Barbara, et al.
Publicado: (2021)

Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma
por: Lucarini, Guendalina, et al.
Publicado: (2022)

Survival and the Sentinel Lymph Node in Melanoma
por: Faries, Mark
Publicado: (2009)

The Evolution of the Sentinel Node Biopsy in Melanoma
por: Allard-Coutu, Alexandra, et al.
Publicado: (2023)

Sentinel node tumor burden in prediction of prognosis in melanoma patients
por: Palve, Johanna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_urnb97q4tgh76ppg390gp1akho